SureTrader SureTrader SureTrader
Home > Boards > US OTC > Cannabis >

Nemus Bioscience, Inc. (NMUS)

Add NMUS Price Alert      Hide Sticky   Hide Intro
Moderator: MasterBlastr
Search This Board:
Last Post: 1/16/2017 11:43:02 PM - Followers: 63 - Board type: Free - Posts Today: 0


NEMUS Bioscience Inc. is a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids. The company's product candidates in preclinical stage include NB1111 for the treatment of glaucoma; and NB1222 used for treating chemotherapy induced nausea and vomiting. Its products under research comprise NB3111 for the treatment of methicillin-resistant Staphylococcus aureus, as well as NB2111 for use in treating chemotherapy induced peripheral neuropathy. The company was founded in 2012 and is headquartered in Costa Mesa, California.

NEMUS Bioscience Inc., a Nevada corporation, is a SEC fully reporting company listed on the  under the symbol NMUS.

Company website:

Filings and disclosure with Level 2 quotes:


(949) 396-0330
E-MAIL: [email protected]


Nemus Bioscience (NMUS) Presentation (47 minutes):

Presentation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 12th, 2016:

Interview with CEO - CMO Dr. Brian Murphy, MD,MPH,MBA  (register for free for complete text)

Major press releases:

Nemus Bioscience Announces Milestones in the Development of Fully Synthetic Clinical-Grade Active Pharmaceutical Ingredient (API) for Drug Candidates NB1111 and NB2111 and Formulation Contract with AMRI and Catalent Pharma Solutions -

Cannabinoid Drug Advancements Take Off After Quantum Shift in U.S. Drug Policy

Nemus Bioscience Announces Presentation of NB1111 Impact on Intraocular Pressure (IOP) in Normotensive Ocular Model at the National Meeting of the American Association of Pharmaceutical Scientists (AAPS)


Nemus Bioscience Announces Enhanced Ocular Tissue Concentration by the Proprietary Prodrug of Tetrahydrocannabinol (NB1111) - Associated With a Superior Decline in Intra-Ocular Pressure (IOP) in an Animal Model


Nemus Bioscience, Inc. Announces Letter of Intent to License Biosynthetic Technology to Manufacture Its Proprietary Cannabinoid Molecules From Teewinot Life Sciences Corp.

NEMUS Bioscience Identifies Unique Cannabidiol (CBD) Derivative as a Lead Candidate in Its Neuropathy-Related Pain Management Program 

CANNAINVESTOR Magazine Top 20 Cannabis Stocks 


NEMUS Bioscience CEO to Present at the 28th Annual ROTH Conference 


NEMUS Bioscience, Inc. Signs Agreement With Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredients 


NEMUS Bioscience CEO to Present at BIO CEO & Investor Conference 


NEMUS Bioscience Prodrug of THC (NB1111) Completes Validation Stage of Glaucoma Testing and Development 


Nemus Enters Into Research Agreement With the University of Mississippi to Develop Cannabinoid-Based Therapies for Chemotherapy-Induced Peripheral Neuropathy (CIPN) 


NMUS Security Details

Share Structure - as of Dec 30, 2016

Authorized Shares: 236,000,000
Outstanding Shares: 
      - Restricted  13,594,621
    - Unrestricted   7,968,542

           - Float   5,005,713 a/o Mar 23, 2016 
   Par Value 0.001

Transfer Agent: Clear Trust, LLC

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
NMUS News: Securities Registration Statement (s-1) 01/20/2017 05:02:36 PM
NMUS News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 01/20/2017 04:32:07 PM
NMUS News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 01/20/2017 04:28:35 PM
NMUS News: Amended Current Report Filing (8-k/a) 01/20/2017 04:24:37 PM
NMUS News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 01/13/2017 04:57:35 PM
News News Alert: Securities Registration Statement (s-1) 01/20/2017 05:02:36 PM
#531  Sticky Note NMUS - Nemus Bioscience, Inc. quick DD MasterBlastr 11/10/16 12:40:30 PM
#958   MasterBlastr 01/16/17 11:43:02 PM
#957   Replying while driving so some of that didn't Cherry_11 01/16/17 09:39:56 PM
#956   First let me say that I'm a shareholder. Cherry_11 01/16/17 09:33:38 PM
#955   How do you come up with the thought MasterBlastr 01/16/17 02:05:13 PM
#954   The only positive from the placement is the Cherry_11 01/16/17 01:14:16 AM
#953   This cannabis issue in the medical subsector hasn't Monksdream 01/13/17 08:19:26 AM
#952   Patience will pay here imo! Regards TURCH 01/11/17 04:40:33 PM
#951   Today's candle renewed my optimism. $NMUS jjr04001 01/11/17 04:18:07 PM
#950   Glad to see you're still here and in jjr04001 01/11/17 11:19:05 AM
#949   Nice action and nice support! glad I doubled TURCH 01/11/17 10:24:02 AM
#948   Why is this popping so much? 1990 01/11/17 10:22:51 AM
#947   There are only 2 salaries plus rent. These Vinpat 01/10/17 10:49:11 PM
#946   Ok, these guys better not be spending this MasterBlastr 01/10/17 07:22:22 PM
#945   NEMUS Bioscience Announces Closing of $1,200,000 Preferred Stock Financing jjr04001 01/10/17 01:06:08 PM
#944   Added more here today, looking for a pop afterhoursearnings 01/09/17 02:04:05 PM
#943   SparkNotes of what I had previously written in 1990 01/06/17 07:49:01 AM
#942   In my opinion it's only trading at .17 1990 01/06/17 07:40:54 AM
#941   thank you for the info. I'm curious, why Vinpat 01/06/17 02:27:21 AM
#940   OWCP is working on multiple drugs and is 1990 01/05/17 11:10:26 PM
#939   It should change. OWCP has a market cap Vinpat 01/05/17 10:31:30 PM
#938   Things can change very quickly afterhoursearnings 01/05/17 09:31:43 PM
#937   I believe that's true and that they've been Vinpat 01/05/17 06:06:47 PM
#936   Interesting . . . Nemus soon to meet MasterBlastr 01/05/17 05:21:50 PM
#935 kunupatel 01/05/17 03:31:11 PM
#934   Market cap. I believe Nemus has the lowest Vinpat 01/05/17 02:50:13 PM
#933   Nice! Looks like a great start to 2017! a surfer 01/03/17 02:05:13 PM
#932   Getting some nice Vol! $NMUS TURCH 01/03/17 01:54:33 PM
#931   Thanks I will get the I-Box updated . MasterBlastr 01/02/17 01:50:11 PM
#930   Updated share structure a/o 12/30/2016: jjr04001 01/02/17 01:03:26 PM
#929   Happy New Year, Nemus Bioscience Board!! ***** Looking MasterBlastr 12/31/16 08:12:03 PM
#928   Easy word to throw out hiding behind a Vinpat 12/30/16 02:37:46 PM
#926   Hopefully you've sold already and don't have to Vinpat 12/29/16 05:33:08 PM
#925   .30 floor breaks soon Death spiral in full effect taubytaub 12/29/16 03:31:37 PM
#924   They have have some monster things going on - MasterBlastr 12/27/16 11:29:13 AM
#923   Could drive a truck through the spread...keeping this afterhoursearnings 12/27/16 11:21:29 AM
#922   He just wasted some money tapping out . MasterBlastr 12/23/16 12:24:55 PM
#921 think so? jjr04001 12/23/16 11:10:19 AM
#920   Trouble taubytaub 12/23/16 11:00:46 AM
#919   Dragonfly doji yesterday. $NMUS jjr04001 12/23/16 07:54:20 AM
#918   That is huge - no reliance on MJ, MasterBlastr 12/20/16 12:00:40 PM
#917   News Conman23 12/20/16 09:57:13 AM
#916   It is a stretch to assume that if MasterBlastr 12/17/16 04:09:27 PM
#915   Lol. So you're saying this management team, that Vinpat 12/14/16 03:02:29 PM
#914   Anyway, do what you like. Not going to Gutts2318 12/14/16 02:43:15 PM
#913   OTC no management ever sell. They only give Gutts2318 12/14/16 02:41:08 PM
#912   Nobody in management sold and these guys aren't Vinpat 12/14/16 01:16:56 PM
#911   Another PR out today. CDEL still bidding for Gutts2318 12/14/16 12:59:19 PM
#910   I am not going to waste time on Gutts2318 12/14/16 12:58:27 PM
#909   Nobody in management sold. Anyone who bought through Vinpat 12/14/16 12:39:52 PM
#908   Their filing is one indicator. April float was Gutts2318 12/14/16 12:18:07 PM